🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Steven Cohen’s XFOR Holdings & Trades

First Buy
Q2 2025
Duration Held
5 Quarters
Largest Add
Q4 2025
+786,488 Shares
Current Position
41,072 Shares
$191,806 Value

Steven Cohen's XFOR Position Overview

Steven Cohen (via Point72 Asset Management, L.P.) currently holds 41,072 shares of X4 Pharmaceuticals, Inc. (XFOR) worth $191,806, representing 0.00% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 5 quarters.

Based on 13F filings, Steven Cohen has maintained this position in XFOR for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 786,488 shares. Largest reduction occurred in Q1 2026, reducing 808,154 shares.

Analysis based on 13F filings available since 2013 Q2

Steven Cohen's X4 Pharmaceuticals (XFOR) Holding Value Over Time

Track share changes against reported price movement

Quarterly X4 Pharmaceuticals (XFOR) Trades by Steven Cohen

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q2 2026 +41,072 New Buy 41,072 $4.67
Q1 2026 -808,154 Sold Out 0 $0.00
Q4 2025 +786,488 Add 3630.06% 808,154 $4.00
Q3 2025 -1 Reduce 0.00% 21,666 $3.42
Q2 2025 +21,667 New Buy 21,667 $1.90

Steven Cohen's X4 Pharmaceuticals Investment FAQs

Steven Cohen first purchased X4 Pharmaceuticals, Inc. (XFOR) in Q2 2025, acquiring 21,667 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Steven Cohen has held X4 Pharmaceuticals, Inc. (XFOR) for 5 quarters since Q2 2025.

Steven Cohen's largest addition to X4 Pharmaceuticals, Inc. (XFOR) was in Q4 2025, adding 808,154 shares worth $3.23 M.

According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 41,072 shares of X4 Pharmaceuticals, Inc. (XFOR), valued at approximately $191,806.

As of the Q2 2026 filing, X4 Pharmaceuticals, Inc. (XFOR) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.

Steven Cohen's peak holding in X4 Pharmaceuticals, Inc. (XFOR) was 808,154 shares, as reported at the end of Q4 2025.